Commercial Credit Report for Aptamer Group PLC

CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals. Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue. We also offer solutions that can help ease private company financial risk assessment. Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively.

A partial report preview for Aptamer Group PLC is shown below. Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database. To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

	Aptamer Group PLC
Windmill House, Innovation Way
Phone: +44 1904217404p:+44 1904217404	YORK, YO10 5BR United Kingdom	Ticker: APTAAPTA

Business Summary

Aptamer Group plc is a developer of Optimer binders in the life sciences industry. It offers custom Optimer selection and development services. It delivers aptamer-based solutions to its customer bases for a range of therapeutic, diagnostic, and target-binding applications. It develops Optimer binders for therapeutics, diagnostics, bioprocessing, and research applications. The Optimer platform delivers aptamer tools that enables researchers and developers across the spectrum of the life sciences. Optimer binders has developed for a range of applications, including therapeutic inhibitors and modulators, drug delivery vehicles, protein purification and separation, biomarker screening and validation, in vitro research, quality control analysis, pharmacokinetic and drug assays, and in vitro diagnostic assays. Optimer act as agonists, antagonists, or cell-type-specific targeting moieties for the delivery of therapeutic agents to target cells and tissues in the treatment of disease.

Scores and Ratings

FRISK^® Score	Z'' Score	PAYCE^® Score	DBT Index	Moody's Rating	Fitch Rating	DBRS Rating
Yes	Yes	-	-	-	-	-

Financials, News and Filings

Latest Statement	Last Audit	News	SEC Filings	Bankruptcy Filings	Suit & Judgment Filings	Tax Lien Filings
12/31/2023	6/30/2023	Yes	-	-	-	-

Industries

SIC Code	Description
7372	Prepackaged software

General Information

Number of Employees:	54	(As of 6/30/2023)
Outstanding Shares:	467,343,673	(As of 12/31/2023)
Stock Exchange:	LON

SITE MAP | ABOUT US | DIRECTORY | STOCK QUOTE: CRMZ | SIGN IN